Talniflumate
Alternative Names: BA 7602-06; LOMUCIN; MSI 1995Latest Information Update: 24 Oct 2021
At a glance
- Originator Bago
- Class Antiasthmatics; Antirheumatics; Benzofurans; Nonsteroidal anti-inflammatories; Pyridines; Small molecules
- Mechanism of Action Mucin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma; Cystic fibrosis; Gastrointestinal disorders
Most Recent Events
- 28 May 2008 Talniflumate is available for licensing (http://www.genaera.com/business_development.php)
- 05 Jul 2007 Discontinued - Phase-II for Cystic fibrosis in Ireland (PO)
- 19 Apr 2005 No development reported - Phase-I for Asthma in Mexico (PO)